These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9210485)

  • 21. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces.
    Randriamahazaka HN; Nigretto JM
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):567-73. PubMed ID: 7841313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.
    Citarella F; Ravon DM; Pascucci B; Felici A; Fantoni A; Hack CE
    Eur J Biochem; 1996 May; 238(1):240-9. PubMed ID: 8665943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H; Miyata T; Iwanaga S; Yamamoto T
    Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible basis for the apparent surface selectivity of the contact activation of human blood coagulation factor XII.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1986 Oct; 25(21):6688-94. PubMed ID: 3491625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of beta 2-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation.
    Schousboe I; Rasmussen MS
    Int J Biochem; 1988; 20(8):787-92. PubMed ID: 3169363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
    Schousboe I; Halkier T
    Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives.
    Røjkaer R; Schousboe I
    Eur J Biochem; 1997 Jul; 247(2):491-6. PubMed ID: 9266689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.
    Griep MA; Fujikawa K; Nelsestuen GL
    Biochemistry; 1985 Jul; 24(15):4124-30. PubMed ID: 3876845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains.
    Citarella F; Aiuti A; La Porta C; Russo G; Pietropaolo C; Rinaldi M; Fantoni A
    Eur J Biochem; 1992 Aug; 208(1):23-30. PubMed ID: 1324834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoactivation of human blood coagulation factor XII on dextran derivatives of different molecular weight.
    Tazi S; Tans G; Hemker HC; Nigretto JM
    Thromb Res; 1992 Sep; 67(6):665-76. PubMed ID: 1279836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.